A Review of Risk in Cervical Cancer: An Analysis of the ASCCP Guidelines & NCI Risk MatrixBD_HPV_Brief MIF 3147-03

Guest: Jeffery Andrews, MD, FRCSC <br> <p>From the approval of an HPV test with extended genotyping to the role of the NCI Risk Matrix, what do we need to know about the ASCCP Risk-Based Management Consensus Guidelines, and how will these updates impact the treatment pathways we recommend to our patients being screening for cervical cancer? Dr. Jeffery Andrews shares guideline recommendations and updates. </p>